Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,655,582
  • Shares Outstanding, K 72,293
  • Annual Sales, $ 2,893 M
  • Annual Income, $ 492,700 K
  • EBIT $ 570 M
  • EBITDA $ 725 M
  • 60-Month Beta 1.09
  • Price/Sales 5.86
  • Price/Cash Flow 26.02
  • Price/Book 6.33

Options Overview Details

View History
  • Implied Volatility 36.92% ( +4.18%)
  • Historical Volatility 143.54%
  • IV Percentile 71%
  • IV Rank 40.92%
  • IV High 56.00% on 02/10/25
  • IV Low 23.71% on 05/17/24
  • Put/Call Vol Ratio 0.17
  • Today's Volume 7
  • Volume Avg (30-Day) 356
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 11,165
  • Open Int (30-Day) 10,690

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.30
  • Number of Estimates 5
  • High Estimate 1.59
  • Low Estimate 1.21
  • Prior Year 1.56
  • Growth Rate Est. (year over year) -16.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
204.37 +12.56%
on 02/21/25
236.71 -2.82%
on 03/07/25
+26.38 (+12.95%)
since 02/20/25
3-Month
197.01 +16.76%
on 02/13/25
348.90 -34.07%
on 01/28/25
-101.37 (-30.59%)
since 12/20/24
52-Week
197.01 +16.76%
on 02/13/25
400.88 -42.62%
on 03/21/24
-164.07 (-41.63%)
since 03/20/24

Most Recent Stories

More News
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 9.11 (-1.62%)
MEDP : 323.01 (-1.36%)
AZTA : 37.29 (+1.39%)
WST : 228.98 (-0.61%)
IQV : 185.05 (-1.01%)
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 9.11 (-1.62%)
UFPT : 213.60 (-0.51%)
AZTA : 37.29 (+1.39%)
WST : 228.98 (-0.61%)
CRL : 168.04 (-3.36%)
3 Top-Rated Dividend Aristocrats to Buy Now for Passive Income

These three companies have increased their dividends for 25-plus years and offer a mix of stability, growth potential, and attractive yields.

KO : 69.39 (+0.16%)
$SPX : 5,693.28 (+0.32%)
SPGI : 496.70 (+0.30%)
WST : 228.98 (-0.61%)
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

FTRE : 9.11 (-1.62%)
UFPT : 213.60 (-0.51%)
AZTA : 37.29 (+1.39%)
RGEN : 142.93 (-1.35%)
WST : 228.98 (-0.61%)
Do Wall Street Analysts Like West Pharmaceutical Services Stock?

West Pharmaceutical Services has trailed behind the broader market over the past year, yet analysts remain highly optimistic, standing by its potential for a strong rebound.

$SPX : 5,693.28 (+0.32%)
WST : 228.98 (-0.61%)
MDEV : 20.59 (+0.58%)
S&P Futures Tick Lower With U.S. Retail Sales Data in Focus

March S&P 500 E-Mini futures (ESH25) are trending down -0.15% this morning, taking a breather at the end of a turbulent week, while investors await a raft of U.S. economic data, with a particular focus...

APP : 309.84 (+4.31%)
AMAT : 154.21 (-0.16%)
ROKU : 74.32 (+3.02%)
TTD : 56.74 (+2.57%)
MU : 103.94 (+1.84%)
ABNB : 126.85 (+0.67%)
ESH25 : 5,704.25 (+0.45%)
TOM.O.DX : 166.400 (-2.15%)
DVA : 150.50 (+0.45%)
RMS.FP : 2,515.000 (+1.09%)
MGM : 33.10 (+1.25%)
INTC : 23.96 (-0.66%)
Stocks Rally as Inflation Fears Recede and Tariffs Delayed

The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +1.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.77%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.43%. March E-mini S&P...

AMAT : 154.21 (-0.16%)
APP : 309.84 (+4.31%)
DE : 477.14 (-0.47%)
TAP : 59.08 (+1.36%)
CSCO : 60.87 (-0.41%)
TTD : 56.74 (+2.57%)
ADI : 206.32 (-1.74%)
DDOG : 104.49 (+0.06%)
KHC : 30.04 (+0.50%)
$IUXX : 19,815.50 (+0.40%)
ASML : 730.11 (-0.65%)
ZNM25 : 111-095 (+0.27%)
Why West Pharmaceutical Services (WST) Stock Is Nosediving

Why West Pharmaceutical Services (WST) Stock Is Nosediving

WST : 228.98 (-0.61%)
WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down

West Pharmaceutical Services, Inc. WST delivered adjusted earnings per share (EPS) of $1.82 in the fourth quarter of 2024, down by a penny year over year. The figure topped the Zacks Consensus Estimate...

BSX : 101.70 (+0.96%)
RMD : 224.53 (+1.12%)
WST : 228.98 (-0.61%)
CAH : 132.72 (+0.45%)
Stocks Supported as PPI Favorable for Fed’s Inflation Measure

The S&P 500 Index ($SPX ) (SPY ) today is up +0.61%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.06%. March E-mini S&P futures (ESH25...

APP : 309.84 (+4.31%)
DE : 477.14 (-0.47%)
TAP : 59.08 (+1.36%)
CSCO : 60.87 (-0.41%)
TTD : 56.74 (+2.57%)
ADI : 206.32 (-1.74%)
DDOG : 104.49 (+0.06%)
KHC : 30.04 (+0.50%)
$IUXX : 19,815.50 (+0.40%)
ASML : 730.11 (-0.65%)
ZNM25 : 111-095 (+0.27%)
ESM25 : 5,755.50 (+0.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical...

See More

Key Turning Points

3rd Resistance Point 241.40
2nd Resistance Point 238.58
1st Resistance Point 234.48
Last Price 228.98
1st Support Level 227.57
2nd Support Level 224.75
3rd Support Level 220.65

See More

52-Week High 400.88
Fibonacci 61.8% 323.00
Fibonacci 50% 298.95
Fibonacci 38.2% 274.89
Last Price 228.98
52-Week Low 197.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar